Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Effect of Oxygen Flow on Aerosol Delivery From a Nebulizer With a Holding Chamber.

Sarhan RM, Elberry AA, Abdelwahab NS, Rabea H, Salem MN, Abdelrahim ME.

Respir Care. 2019 Aug 6. pii: respcare.06639. doi: 10.4187/respcare.06639. [Epub ahead of print]

PMID:
31387895
2.

Inhaled salbutamol from aerolizer and diskus at different inhalation flows, inhalation volume and number of inhalations in both healthy subjects and COPD patients.

Boshra MS, Almeldien AG, Eldin RS, Elberry AA, Abdelwahab NS, Salem MN, Rabea H, Abdelrahim MEA.

Exp Lung Res. 2019 Apr - May;45(3-4):84-91. doi: 10.1080/01902148.2019.1621408. Epub 2019 Jun 1.

PMID:
31155973
3.

Aerosol Delivery Through an Adult High-Flow Nasal Cannula Circuit Using Low-Flow Oxygen.

Madney YM, Fathy M, Elberry AA, Rabea H, Abdelrahim ME.

Respir Care. 2019 Apr;64(4):453-461. doi: 10.4187/respcare.06345. Epub 2019 Jan 22.

PMID:
30670669
4.

Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers.

Boshra MS, Almeldien AG, Salah Eldin R, Elberry AA, Abdelwahab NS, Nabil Salem M, Rabea H, Abdelrahim MEA.

Exp Lung Res. 2018 May - Jun;44(4-5):211-216. doi: 10.1080/01902148.2018.1489015. Epub 2018 Oct 22.

PMID:
30346848
5.

Effects of Fill Volume and Humidification on Aerosol Delivery During Single-Limb Noninvasive Ventilation.

Saeed H, Mohsen M, Salah Eldin A, Elberry AA, Hussein RR, Rabea H, Abdelrahim ME.

Respir Care. 2018 Nov;63(11):1370-1378. doi: 10.4187/respcare.06022. Epub 2018 Aug 14.

PMID:
30108135
6.

Performance of Large Spacer Versus Nebulizer T-Piece in Single-Limb Noninvasive Ventilation.

Harb HS, Elberry AA, Rabea H, Fathy M, Abdelrahim ME.

Respir Care. 2018 Nov;63(11):1360-1369. doi: 10.4187/respcare.05976. Epub 2018 Aug 7.

PMID:
30087193
7.

Effect of a Nebulizer Holding Chamber on Aerosol Delivery.

Sarhan RM, Elberry AA, Abdelwahab NS, Rabea H, Salem MN, Abdelrahim ME.

Respir Care. 2018 Sep;63(9):1125-1131. doi: 10.4187/respcare.06061. Epub 2018 May 22.

PMID:
29789412
8.

Modeling and optimization of nebulizers' performance in non-invasive ventilation using different fill volumes: Comparative study between vibrating mesh and jet nebulizers.

Saeed H, Ali AMA, Elberry AA, Eldin AS, Rabea H, Abdelrahim MEA.

Pulm Pharmacol Ther. 2018 Jun;50:62-71. doi: 10.1016/j.pupt.2018.04.005. Epub 2018 Apr 7.

PMID:
29635073
9.

Lung deposition and systemic bioavailability of different aerosol devices with and without humidification in mechanically ventilated patients.

Moustafa IOF, Ali MRA, Al Hallag M, Rabea H, Fink JB, Dailey P, Abdelrahim MEA.

Heart Lung. 2017 Nov - Dec;46(6):464-467. doi: 10.1016/j.hrtlng.2017.08.004. Epub 2017 Sep 4.

PMID:
28882385
10.

Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation.

ElHansy MHE, Boules ME, El Essawy AFM, Al-Kholy MB, Abdelrahman MM, Said ASA, Hussein RRS, Abdelrahim ME.

Pulm Pharmacol Ther. 2017 Aug;45:159-163. doi: 10.1016/j.pupt.2017.06.004. Epub 2017 Jun 13.

PMID:
28627376
11.

Effect of Honey and Royal Jelly against Cisplatin-Induced Nephrotoxicity in Patients with Cancer.

Osama H, Abdullah A, Gamal B, Emad D, Sayed D, Hussein E, Mahfouz E, Tharwat J, Sayed S, Medhat S, Bahaa T, Abdelrahim MEA.

J Am Coll Nutr. 2017 Jul;36(5):342-346. doi: 10.1080/07315724.2017.1292157. Epub 2017 May 26.

PMID:
28548561
12.

Clinical outcome associated with the use of different inhalation method with and without humidification in asthmatic mechanically ventilated patients.

Moustafa IOF, ElHansy MHE, Al Hallag M, Fink JB, Dailey P, Rabea H, Abdelrahim MEA.

Pulm Pharmacol Ther. 2017 Aug;45:40-46. doi: 10.1016/j.pupt.2017.04.007. Epub 2017 Apr 20.

PMID:
28435031
13.

In-vitro/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation.

Hassan A, Salah Eldin R, Abdelrahman MM, Abdelrahim ME.

Exp Lung Res. 2017 Feb;43(1):19-28. doi: 10.1080/01902148.2017.1282993. Epub 2017 Feb 22.

PMID:
28394653
14.

ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt.

Kassem AB, Salem SE, Abdelrahim ME, Said AS, Salahuddin A, Hussein MM, Bahnassy AA.

Exp Mol Pathol. 2017 Feb;102(1):78-85. doi: 10.1016/j.yexmp.2017.01.006. Epub 2017 Jan 12.

PMID:
28088319
15.

Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit.

Rabea H, Ali AM, Salah Eldin R, Abdelrahman MM, Said AS, Abdelrahim ME.

Eur J Pharm Sci. 2017 Jan 15;97:182-191. doi: 10.1016/j.ejps.2016.11.018. Epub 2016 Nov 17.

PMID:
27866986
16.

Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients.

Ibrahim MK, Salama H, Abd El Rahman M, Dawood RM, Bader El Din NG, Salem HF, Abdelrahim ME, Omran D, Omran MH, El-Wakeel KH, Abdelhafez TH, Khedr A, El Awady MK.

J Interferon Cytokine Res. 2016 Dec;36(12):698-705. Epub 2016 Oct 11.

PMID:
27726464
17.

In vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation.

ElHansy MHE, Boules ME, Farid H, Chrystyn H, El-Maraghi SK, Al-Kholy MB, El-Essawy AFM, Abdelrahman MM, Said ASA, Hussein RRS, Rabea H, Abdelrahim MEA.

Pharm Dev Technol. 2017 Sep;22(6):844-849. doi: 10.1080/10837450.2016.1221427. Epub 2016 Aug 30.

PMID:
27493018
18.

Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial.

Zedan MM, El-Refaey A, Zaghloul H, Abdelrahim ME, Osman A, Zedan MM, Eltantawy N.

J Nephrol. 2016 Aug;29(4):585-92. doi: 10.1007/s40620-016-0297-2. Epub 2016 Mar 31.

PMID:
27032639
19.

Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.

Salem HF, Kharshoum RM, Abdel Hakim LF, Abdelrahim ME.

J Liposome Res. 2016 Dec;26(4):324-35. doi: 10.3109/08982104.2016.1140182. Epub 2016 Feb 12.

PMID:
26872552
20.

In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients.

Hussein RRS, M A Ali A, Salem HF, Abdelrahman MM, Said ASA, Abdelrahim MEA.

Pharm Dev Technol. 2017 Nov;22(7):871-880. doi: 10.3109/10837450.2015.1116567. Epub 2015 Nov 25.

PMID:
26608180
21.

Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.

Abdelbary AA, Al-mahallawi AM, Abdelrahim ME, Ali AM.

Int J Nanomedicine. 2015 Oct 12;10:6339-53. doi: 10.2147/IJN.S91631. eCollection 2015.

22.

Droplet aerodynamics, cellular uptake, and efficacy of a nebulizable corticosteroid nanosuspension are superior to a micronized dosage form.

Britland S, Finter W, Chrystyn H, Eagland D, Abdelrahim ME.

Biotechnol Prog. 2012 Sep-Oct;28(5):1152-9. doi: 10.1002/btpr.1616. Epub 2012 Sep 21.

PMID:
22887984
23.

Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow.

Abdelrahim ME, Assi KH, Chrystyn H.

Pharm Dev Technol. 2013 Jul-Aug;18(4):944-9. doi: 10.3109/10837450.2011.620970. Epub 2011 Oct 10.

PMID:
21981637
24.

The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients.

Abdelrahim ME, Plant PK, Chrystyn H.

Int J Pharm. 2011 Nov 28;420(2):313-8. doi: 10.1016/j.ijpharm.2011.09.005. Epub 2011 Sep 16.

PMID:
21944891
25.

Relative bioavailability of terbutaline to the lung following inhalation, using urinary excretion.

Abdelrahim ME, Assi KH, Chrystyn H.

Br J Clin Pharmacol. 2011 Apr;71(4):608-10. doi: 10.1111/j.1365-2125.2010.03873.x.

26.

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler.

Salem H, Abdelrahim M, Eid KA, Sharaf M.

Int J Nanomedicine. 2011;6:311-20. doi: 10.2147/IJN.S14309. Epub 2011 Feb 6.

27.

Disposable versus reusable jet nebulizers for cystic fibrosis treatment with tobramycin.

Vecellio L, Abdelrahim ME, Montharu J, Galle J, Diot P, Dubus JC.

J Cyst Fibros. 2011 Mar;10(2):86-92. doi: 10.1016/j.jcf.2010.10.004. Epub 2010 Nov 12.

28.

In-vitro characterisation of the nebulised dose during non-invasive ventilation.

Abdelrahim ME, Plant P, Chrystyn H.

J Pharm Pharmacol. 2010 Aug;62(8):966-72. doi: 10.1111/j.2042-7158.2010.01134.x.

PMID:
20663030
29.

Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.

Abdelrahim ME.

Pharm Dev Technol. 2011 Apr;16(2):137-45. doi: 10.3109/10837450903511194. Epub 2010 Jan 25.

PMID:
20100034
30.

Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions.

Abdelrahim ME.

Respir Med. 2010 May;104(5):682-9. doi: 10.1016/j.rmed.2009.11.014. Epub 2009 Dec 8.

31.

Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers.

Amani A, Chrystyn H, Clark BJ, Abdelrahim ME, York P.

J Pharm Pharmacol. 2009 Dec;61(12):1625-30. doi: 10.1211/jpp/61.12.0006.

PMID:
19958584
32.

Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method.

Abdelrahim ME, Chrystyn H.

J Aerosol Med Pulm Drug Deliv. 2009 Mar;22(1):19-28.

PMID:
19392586

Supplemental Content

Loading ...
Support Center